Nanohybrid Scaffolds for the Treatment of Diabetic Wounds

  • Veera Venkata Satyanarayana Reddy KarriEmail author
  • Gowthamarajan Kuppusamy
  • Ashish Devidas Wadhwani
  • Rajkumar Malayandi
Part of the Recent Clinical Techniques, Results, and Research in Wounds book series (RCTRRW, volume 3)


Diabetic wounds are the main cause of mortality in patients with diabetes. Recent reports suggest that even though the pathophysiology of diabetic wound is multifactorial, persistent inflammation with infections and lack of tissue regeneration (tissue management) leads to impaired wound healing in diabetes and leaves these wounds in a chronic nonhealing stage. Hence, the aim of this investigation is to formulate drug (curcumin and doxycycline hyclate)-loaded biomimetic collagen–alginate composite nanohybrid scaffolds which have both anti-inflammatory and antibacterial activities for potential tissue regeneration in diabetic wounds. The prepared novel composite nanohybrid scaffolds satisfied the properties of an ideal diabetic wound dressing in terms of mechanical strength, swelling, porosity, biodegradation, biocompatibility, controlled release, cell adhesion, and proliferation with antibacterial anti-inflammatory properties which are crucial for tissue regeneration in diabetic wounds. Hence, this study suggests that the synergistic combination of curcumin, doxycycline hyclate (anti-inflammatory and antibacterial), chitosan (controlled drug carrier, wound healing), collagen (established wound healer), and alginate (biomaterial for regenerative medicine) is a promising strategy to address various pathological manifestations of diabetic wounds and has better wound healing capability.


  1. 1.
    Allen RJ Jr, Soares MA, Haberman ID, Szpalski C, Schachar J, Lin CD, Nguyen PD, Saadeh PB, Warren SM (2014) Combination therapy accelerates diabetic wound closure. PLoS One 9(3):e92667PubMedGoogle Scholar
  2. 2.
    Karri VNR, Kuppusamy G, Mulukutla S, Sood S, Malayandi R (2015) Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers. J Excipients Food Chem 6(1):7–22Google Scholar
  3. 3.
    Kant V, Gopal A, Pathak NN, Kumar P, Tandan SK, Kumar D (2014) Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. Int Immunopharmacol 20(2):322–330PubMedGoogle Scholar
  4. 4.
    Mat Saad AZ, Khoo TL, Halim AS (2013) Wound bed preparation for chronic diabetic foot ulcers. ISRN Endocrinol 2013:608313PubMedPubMedCentralGoogle Scholar
  5. 5.
    Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, Hao JY (2002) Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 59(3):438–449PubMedGoogle Scholar
  6. 6.
    Sripriya R, Kumar MS, Sehgal PK (2004) Improved collagen bilayer dressing for the controlled release of drugs. J Biomed Mater Res B Appl Biomater 70((2):389–396Google Scholar
  7. 7.
    Meaume S, Vallet D, Nguyen Morere M, Téot L (2005) Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care 14(9):411–419PubMedGoogle Scholar
  8. 8.
    Shanmugasundaram N, Sundaraseelan J, Uma S, Selvaraj D, Babu M (2006) Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. J Biomed Mater Res B Appl Biomater 77((2):378–388Google Scholar
  9. 9.
    Cullen B, Smith R, Mcculloch E, Silcock D, Morrison L (2002) Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 10(1):16–25PubMedGoogle Scholar
  10. 10.
    Schönfelder U, Abel M, Wiegand C, Klemm D, Elsner P, Hipler U-C (2005) Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 26(33):6664–6673PubMedGoogle Scholar
  11. 11.
    Mahmoud AA, Salama AH (2016) Norfloxacin-loaded collagen/chitosan scaffolds for skin reconstruction: Preparation, evaluation and in-vivo wound healing assessment. Eur J Pharm Sci 83:155–165PubMedGoogle Scholar
  12. 12.
    Brahatheeswaran DY, Yoshida Y, Toru M, Sakthi Kumar D (2011) Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci 2011:290602Google Scholar
  13. 13.
    Yannas IV (1990) Biologically active analogues of the extracellular matrix: artificial skin and nerves. Angewandte Chemie Int Ed 29(1):20–35Google Scholar
  14. 14.
    Hou C, Shen L, Huang Q, Mi J, Wu Y, Yang M, Zeng W, Li L, Chen W, Zhu C (2013) The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer. Biomaterials 34(1):112–120PubMedGoogle Scholar
  15. 15.
    McCarty SM, Percival SL (2013) Proteases and delayed wound healing. Adv Wound Care (New Rochelle) 2(8):438–447Google Scholar
  16. 16.
    Wang W, Lin S, Xiao Y, Huang Y, Tan Y, Cai L, Li X (2008) Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci 82(3–4):190–204PubMedGoogle Scholar
  17. 17.
    Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Kelman Cohen I (1997) Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 5(1):23–32PubMedGoogle Scholar
  18. 18.
    Lee CH, Singla A, Lee Y (2001) Biomedical applications of collagen. Int J Pharm 221(1–2):1–22PubMedGoogle Scholar
  19. 19.
    Pieper JS, Oosterhof A, Dijkstra PJ, Veerkamp JH, van Kuppevelt TH (1999) Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20(9):847–858PubMedGoogle Scholar
  20. 20.
    Schulz Torres D, Freyman TM, Yannas IV, Spector M (2000) Tendon cell contraction of collagen–GAG matrices in vitro: effect of cross-linking. Biomaterials 21(15):1607–1619Google Scholar
  21. 21.
    Chen G, Ushida T, Tateishi T (2002) Scaffold design for tissue engineering. Macromol Biosci 2(2):67–77Google Scholar
  22. 22.
    Lee M, Lo AC, Cheung PT, Wong D, Chan BP (2009) Drug carrier systems based on collagen–alginate composite structures for improving the performance of GDNF-secreting HEK293 cells. Biomaterials 30(6):1214–1221PubMedGoogle Scholar
  23. 23.
    Lin YC, Brayfield CA, Gerlach JC, Peter Rubin J, Marra KG (2009) Peptide modification of polyethersulfone surfaces to improve adipose-derived stem cell adhesion. Acta Biomater 5(5):1416–1424PubMedGoogle Scholar
  24. 24.
    Ma L, Gao C, Mao Z, Zhou J, Shen J, Hu X, Han C (2003) Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 24(26):4833–4841Google Scholar
  25. 25.
    Mohandas A, Kumar PTS, Raja B, Lakshmanan VK, Jayakumar R (2015) Exploration of alginate hydrogel/nano zinc oxide composite bandages for infected wounds. Int J Nanomedicine 10(Suppl 1):53–66PubMedPubMedCentralGoogle Scholar
  26. 26.
    Karri VVSR, Kuppusamy G, Satish Kumar M, Malayandi R (2015) Multiple biological actions of curcumin in the management of diabetic foot ulcer complications: a systematic review. Trop Med Surg 3(179):2–10Google Scholar
  27. 27.
    Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41(13):1955–1968PubMedGoogle Scholar
  28. 28.
    Gong C, Wu Q, Wang Y, Zhang D, Luo F, Zhao X, Wei Y, Qian Z (2013) A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials 34(27):6377–6387PubMedGoogle Scholar
  29. 29.
    Archana D, Dutta PK, Dutta J (2016) Chitosan: a potential therapeutic dressing material for wound healing. In: Dutta KP (ed) Chitin and Chitosan for regenerative medicine. Springer, New Delhi, pp 193–227Google Scholar
  30. 30.
    Rajitha P, Gopinath D, Biswas R, Sabitha M, Jayakumar R (2016 Aug) Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases. Expert Opin Drug Deliv 13(8):1177–1194PubMedGoogle Scholar
  31. 31.
    Adhirajan N, Shanmugasundaram N, Shanmuganathan S, Babu M (2009) Collagen-based wound dressing for doxycycline delivery: in-vivo evaluation in an infected excisional wound model in rats. J Pharm Pharmacol 61(12):1617–1623PubMedGoogle Scholar
  32. 32.
    Akbik D, Ghadiri M, Chrzanowski W, Rohanizadeh R (2014) Curcumin as a wound healing agent. Life Sci 116(1):1–7PubMedGoogle Scholar
  33. 33.
    Calvo P, Remunan-Lopez C, Vila-Jato J, Alonso M (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63(1):125–132Google Scholar
  34. 34.
    Sang L, Luo D, Xu S, Wang X, Li X (2011) Fabrication and evaluation of biomimetic scaffolds by using collagen–alginate fibrillar gels for potential tissue engineering applications. Mater Sci Eng C 31(2):262–271Google Scholar
  35. 35.
    Cheung DT, Perelman N, Ko EC, Nimni M (1985) Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues. Connect Tiss Res 13(2):109–115Google Scholar
  36. 36.
    Swann DA, Balazs EA (1966) Determination of the hexosamine content of macro-molecules with manual and automated techniques using the p-dimethylaminobenzaldehyde reaction. Biochim Biophys Acta (BBA) - General Subjects 130(1):112–129Google Scholar
  37. 37.
    Nguyen VC, Nguyen VB, Hsieh M-F (2013) Curcumin-loaded chitosan/gelatin composite sponge for wound healing application. Int J Polym Sci 2013:7–13Google Scholar
  38. 38.
    Gorczyca G, Tylingo R, Szweda P, Augustin E, Sadowska M, Milewski S (2014) Preparation and characterization of genipin cross-linked porous chitosan–collagen–gelatin scaffolds using chitosan–CO2 solution. Carbohydr Polym 102:901–911PubMedGoogle Scholar
  39. 39.
    Anisha B, Biswas R, Chennazhi K, Jayakumar R (2013) Chitosan–hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds. Int J Biolog Macromol 62:310–320Google Scholar
  40. 40.
    Draize JH, Woodard G, Calvery HO (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharm Exp Therap 82(3):377–390Google Scholar
  41. 41.
    Fernandez-Urrusuno R, Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ (1999) Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 16(10):1576–1581Google Scholar
  42. 42.
    Chaubey P, Patel RR, Mishra B (2014) Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Exp Opin Drug Deliv 11(8):1163–1181Google Scholar
  43. 43.
    Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML (2011) Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 22(4):045101PubMedGoogle Scholar
  44. 44.
    Kim Y, Kim G (2013) Collagen/alginate scaffolds comprising core (PCL)-shell (collagen/alginate) struts for hard tissue regeneration: fabrication, characterisation, and cellular activities. J Mater Chem B 1(25):3185–3194Google Scholar
  45. 45.
    Jithendra P, Rajam AM, Kalaivani T, Mandal AB, Rose C (2013) Preparation and characterization of aloe vera blended collagen-chitosan composite scaffold for tissue engineering applications. ACS Appl Mater Interfaces 5(15):7291–7298PubMedGoogle Scholar
  46. 46.
    Sailakshmi G, Mitra T, Gnanamani A (2013) Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications. Progr Biomater 2(1):1–12Google Scholar
  47. 47.
    Archana D, Singh BK, Dutta J, Dutta PK (2013) In vivo evaluation of chitosan–PVP–titanium dioxide nanocomposite as wound dressing material. Carbohydr Polym 95(1):530–539PubMedGoogle Scholar
  48. 48.
    Food, Administration D, Health UDo, Services H (1995) Use of International Standard ISO 10993, biological evaluation of medical devices–Part 1: Evaluation and testing; G95-1. Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation, Rockville, MDGoogle Scholar
  49. 49.
    Gillette BM, Jensen JA, Wang M, Tchao J, Sia SK (2010) Dynamic hydrogels: switching of 3d microenvironments using two-component naturally derived extracellular matrices. Adv Mater 22(6):686–691PubMedGoogle Scholar
  50. 50.
    Kähäri V-M, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6(5):199–213PubMedGoogle Scholar
  51. 51.
    Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867–1876PubMedGoogle Scholar
  52. 52.
    Adhirajan N, Shanmugasundaram N, Shanmuganathan S, Babu M (2009) Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth. Eur J Pharm Sci 36(2):235–245PubMedGoogle Scholar
  53. 53.
    Tettamanti G, Grimaldi A, Rinaldi L, Arnaboldi F, Congiu T, Valvassori R et al (2004) The multifunctional role of fibroblasts during wound healing in Hirudo medicinalis (Annelida, Hirudinea). Biol Cell 96(6):443–455PubMedGoogle Scholar
  54. 54.
    Bainbridge P (2013) Wound healing and the role of fibroblasts. J Wound Care 22(8):407–412PubMedGoogle Scholar
  55. 55.
    Blakytny R, Jude E (2006) The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 23(6):594–608PubMedGoogle Scholar
  56. 56.
    Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117(5):1219–1222PubMedPubMedCentralGoogle Scholar
  57. 57.
    Tsuboi R, Shi C-M, Rifkin DB, Ogawa H (1992) A wound healing model using healing-impaired diabetic mice. J Dermatol 19(11):673–675PubMedGoogle Scholar
  58. 58.
    Cai L, Wang J, Li Y, Sun X, Wang L, Zhou Z, Kang YJ (2005) Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 54(6):1829–1837PubMedGoogle Scholar
  59. 59.
    Connelly K, Kelly D, Gilbert R (2007) Clinically relevant models of diabetic cardiac complications. Circ Res 101(6):e78PubMedGoogle Scholar
  60. 60.
    Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadán-Diehl C, Goldberg IJ (2007) Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100(10):1415–1427PubMedGoogle Scholar
  61. 61.
    Schäffer MR, Tantry U, Efron PA, Ahrendt GM, Thornton FJ, Barbul A (1997) Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 121(5):513–519PubMedGoogle Scholar
  62. 62.
    Rayment EA, Upton Z, Shooter GK (2008) Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 158(5):951–961PubMedGoogle Scholar
  63. 63.
    Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40(6):1334–1347PubMedGoogle Scholar
  64. 64.
    Yang C, Zhu P, Yan L, Chen L, Meng R, Lao G (2009) Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats. J Am Podiat Med Assoc 99(6):489–496Google Scholar
  65. 65.
    McCarty SM, Percival SL (2013) Proteases and delayed wound healing. Adv Wound Care 2(8):438–447Google Scholar
  66. 66.
    Xu F, Zhang C, Graves DT (2013) Abnormal cell responses and role of TNF-in impaired diabetic wound healing. Biomed Res Int 2013:754802PubMedPubMedCentralGoogle Scholar
  67. 67.
    Mast BA, Schultz GS (1996) Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 4(4):411–420PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Veera Venkata Satyanarayana Reddy Karri
    • 1
    • 2
    Email author
  • Gowthamarajan Kuppusamy
    • 1
    • 2
  • Ashish Devidas Wadhwani
    • 3
    • 2
  • Rajkumar Malayandi
    • 4
  1. 1.Department of PharmaceuticsJSS College of PharmacyOotacamundIndia
  2. 2.Jagadguru Sri Shivarathreeshwara UniversityMysuruIndia
  3. 3.Department of Pharmaceutical Biotechnology, JSS College of PharmacyOotacamundIndia
  4. 4.Pharmacokinetic Research and Development, Sun Pharmaceutical Industries Ltd.Village TandaljaIndia

Personalised recommendations